1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers
Davis W, Mantsios A, Metzner A, Talan A, Kwait J, Rodriguez H, Karver T, Barker S, Suarez A, Fernandez R, Rodriguez-Diaz C, Taggart T, Oglesby A, Garris C, Wohl D, Barrington C, Kerrigan D. 1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers. Open Forum Infectious Diseases 2023, 10: ofad500.1371. PMCID: PMC10677220, DOI: 10.1093/ofid/ofad500.1371.Peer-Reviewed Original ResearchPre-exposure prophylaxisHealthcare providersLA PrEPInjectable pre-exposure prophylaxisHIV pre-exposure prophylaxisExit interviewsPrEP conversationsClinic visitsPrEP knowledgePrEP useClinical visitsViiV HealthcarePrEP usersHIV preventionSide effectsFDA approvalCare optionsPrEPAcceptable deliveryKnowledge deficitsFormative researchProphylaxisVisitsMinor suggestionsDiverse populations